论文部分内容阅读
目的:提高肝衰竭(HF)的临床疗效。方法:用新型膜材料制成血液透析滤过器,在常规药物治疗基础上,对治疗组HF病人进行血液透析(HDF),1周1～2次。配合特制中草药汤剂于HDF前后进行口服(或灌肠),对照组只用常规药物治疗。结果:治疗组26例,治愈14例,好转8例,治愈率53.8%,治愈好转率84.6％,1周2次HDF后TBil平均下降82.1μmol/L;对照组22例,同期治疗后,治愈2例,好转6例,治愈率9%,治愈好转率36.4%,1周后TBil平均下降10μmol/L。结论:人工肝支持加中药治疗HF,可提高HF的临床治愈好转率。
Objective: To improve the clinical efficacy of liver failure (HF). Methods: A hemodiafiltration device was made with a new type of membrane material. On the basis of conventional drug therapy, hemodialysis (HDF) was performed on the HF patients in the treatment group 1 ~ 2 times a week. With the special Chinese herbal decoction before and after HDF oral (or enema), the control group only with conventional drugs. Results: In the treatment group, 26 cases were cured, 14 cases were cured, 8 cases improved, the cure rate was 53.8%, the healing improvement rate was 84.6%. The average TBil dropped 82.1μmol / L after two HDFs once a week. In the control group, 22 cases were cured after the same period 2 cases improved in 6 cases, the cure rate was 9%, the cure rate was 36.4%. After 1 week, TBil decreased 10μmol / L on average. Conclusion: Artificial liver support plus traditional Chinese medicine in the treatment of HF can improve the cure rate of HF clinically.